Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cloning: present and perspectives].

J P Renard1, E Legouy, S Chastant

  • 1Unité de biologie du développement, INRA, Jouy-en-Josas.

Contraception, Fertilite, Sexualite (1992)
|August 4, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcervical collection of bovine embryos up to Day 21: an 8-year overview.

Theriogenology·2015
Same author

Magnetism of A-copper(II) bimetallic chain compounds (A = iron, cobalt, nickel): one- and three-dimensional behaviors.

Inorganic chemistry·2013
Same author

A euglycaemic/non-diabetic perinatal environment does not alleviate early beta cell maldevelopment and type 2 diabetes risk in the GK/Par rat model.

Diabetologia·2012
Same author

Comparison of cloned and non-cloned Holstein heifers in muscle contractile and metabolic characteristics.

Animal : an international journal of animal bioscience·2012
Same author

Quality and safety of bovine clones and their products.

Animal : an international journal of animal bioscience·2012
Same author

Post mortem evolution of myofilament spacing and extracellular space in veal muscle.

Meat science·2011
Same journal

[Inflammatory and/or locally advanced breast cancers. Difficulty evaluating the response to initial chemotherapy].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Proximal tubal unblocking by selective salpingography, apropos of 8 cases].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Anatomoclinical correlations of endometriosis].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Effects of raloxifene on bone loss and fracture risk in the menopausal woman].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Cytological screening of uterine cervical cancer by samples in liquid medium (CytoRich). Preliminary study of a series of 111 292 patients].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Diabetes before pregnancy, apropos of 143 cases].

Contraception, fertilite, sexualite (1992)·2000
See all related articles

Human embryonic cells from somatic cloning could enable self-grafting for therapies. However, animal research suggests this approach requires careful consideration due to potential risks.

Area of Science:

  • Reproductive biology
  • Stem cell science
  • Medical ethics

Context:

  • Somatic cell nuclear transfer (SCNT) offers potential for generating patient-specific embryonic stem cells.
  • Therapeutic applications of cloned human embryonic cells are being explored for regenerative medicine.
  • Ethical and safety considerations are paramount in human cloning research.

Purpose:

  • To explore the potential of human embryonic cells derived from somatic cloning for therapeutic self-grafting.
  • To review existing animal research data relevant to the safety and efficacy of therapeutic cloning.

Summary:

  • Human embryonic cells generated via somatic cloning could facilitate autologous transplantation, minimizing immune rejection.
  • Animal studies indicate significant challenges and risks associated with therapeutic cloning, necessitating caution.

Related Experiment Videos

  • The feasibility of self-grafting using cloned human embryonic cells requires thorough investigation and risk assessment.

    • Impact:

    • Advances in regenerative medicine through patient-specific cell therapies.
    • Informed ethical debate on the use of human embryonic stem cells.
    • Development of stringent safety protocols for cloning technologies.